Abbott Laboratories stock is trading flat in after-hours action at 104.06 dollars, matching its regular session closing price. The company recently finalized its 21 billion dollar acquisition of Exact Sciences, a deal that officially closed on March 23, 2026, to expand its footprint in the cancer diagnostics market. While this major M&A activity was confirmed via an 8-K filing, the market appears to have already digested the news during the regular session, resulting in no significant price movement following the closing bell. No other company-specific catalysts or earnings reports have been released in the last 24 hours to drive volatility.
Click any event to see why ABT moved that day
No significant catalyst events detected.